Ellington Financial Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ellington Financial Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.74M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $117.83M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $60.90M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($85.34M) | Mar 3, 2025 |
| FY2021 | Dec 31, 2021 | $34.27M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $20.56M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $32.66M | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $37.86M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $63.16M | Mar 1, 2022 |
| FY2021 | Sep 30, 2020 | $46.20M | Mar 1, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2018 | $10.21M | Mar 16, 2021 |
| FY2020 | Sep 30, 2018 | $11.68M | Mar 16, 2021 |
| FY2020 | Jun 30, 2018 | $10.99M | Mar 16, 2021 |
| FY2020 | Mar 31, 2018 | $10.24M | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $7.06M | Mar 14, 2019 |
| FY2018 | Sep 30, 2017 | $7.90M | Mar 14, 2019 |
| FY2018 | Jun 30, 2017 | $8.43M | Mar 14, 2019 |
| FY2018 | Mar 31, 2017 | $11.78M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $9.03M | Mar 15, 2018 |
| FY2017 | Sep 30, 2016 | $6.39M | Mar 15, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($925.46M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($430.53M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($241.86M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $42.69M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $51.29M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $119.51M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $79.25M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | ($494.18M) | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | ($462.93M) | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $69.69M | Mar 15, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.35B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $16.32B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $15.32B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $14.09B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.18B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.41B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $4.34B | Mar 16, 2021 |
| FY2020 | Dec 31, 2018 | $3.97B | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $2.99B | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.41B | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.48B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $14.73B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $13.78B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $12.87B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.85B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.49B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.47B | Mar 16, 2021 |
| FY2020 | Dec 31, 2018 | $3.38B | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $2.37B | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.77B | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.52B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.20B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.29B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $885.22M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $829.27M | Mar 16, 2021 |
| FY2020 | Dec 31, 2018 | $563.83M | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $600.10M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $637.66M | Mar 15, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($412.96M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($375.11M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($353.36M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | ($290.88M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($97.28M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($141.52M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($103.56M) | Mar 16, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $201.89M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $192.39M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $228.93M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $217.05M | Mar 2, 2026 |
| FY2022 | Oct 3, 2022 | $20.37M | Mar 1, 2023 |
| FY2024 | Dec 31, 2021 | $92.66M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $111.65M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $72.30M | Mar 1, 2023 |
| FY2020 | Dec 31, 2018 | $44.66M | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $47.23M | Mar 14, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $85.80M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $85.56M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $85.30M | Mar 16, 2021 |
| FY2020 | Dec 31, 2018 | $85.04M | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $84.77M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Mar 15, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | 1 | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 15, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | 1 | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 15, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 113.14M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 90.68M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 83.00M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | 63.81M | Mar 2, 2026 |
| FY2024 | Dec 31, 2021 | 57.46M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | 43.78M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | 38.65M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | 29.80M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | 31.34M | Mar 16, 2021 |
| FY2018 | Dec 31, 2016 | 32.29M | Mar 14, 2019 |